Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
TARGETMOL CHEMICALS INC JH-RE-06 5MG
Supplier: TARGETMOL CHEMICALS INC T156115MG
Also available in 1 mg 10 mg 25 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing the recruitment of mutagenic POL(zeta). JH-RE-06 is an effective REV1-REV7 interface inhibitor (IC50=0.78 uM; Kd=0.42 uM) which targets REV1 that interacts with the REV7 subunit of POL(zeta). JH-RE-06 also improves chemotherapy. purity: 99%
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?